Biogen Inc. (BIIB) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

83% of 6 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
ARCADIA ARCADIA 05/20/2015 3 months $399.32 $401.15 +0.46% 1 Active
Comments:
Johnny Vidal Johnny Vidal 05/08/2015 1 month $398.17 $401.15 +0.75% 1 Active
Comments:
StockC StockC 05/06/2015 3 months $383.56 $401.15 +4.59% 4 Active
Comments: Strong product pipeline coming.
fabdalpiero fabdalpiero 05/06/2015 3 months $383.56 $401.15 +4.59% 4 Active
Comments: buy on average with rising target by the end of the period.
Netteligent Netteligent 03/24/2015 3 months $452.71 $401.15 -11.39% 11 Active
Comments:
Cezar, CFTe Cezar, CFTe 06/21/2014 1 Year $319.59 $401.15 +25.52% 25 Active
Comments: BIIB broke out of the Ichimoku Cloud on rising volume! Technical Indicators are in sync for BIIB!
artmustaches artmustaches 01/15/2014 1 Year $297.47 $348.75 +17.24% 17 Ended
Comments:
NoraJRector NoraJRector 01/06/2014 1 month $277.40 $299.93 +8.12% -8 Ended
Comments:
Ingrid Ingrid 11/05/2013 1 Year $238.62 $322.06 +34.97% 34 Ended
Comments: Sector growing
Peter Bentsen Peter Bentsen 09/24/2013 3 months $242.67 $282.26 +16.31% 16 Ended
Comments: Strong buy
JOKER66 JOKER66 03/28/2013 3 months $182.68 $120.04 -34.29% -34 Ended
Comments:
klaus_neuhaus klaus_neuhaus 01/03/2013 1 month $146.44 $157.30 +7.42% 7 Ended
Comments: strong buy recommendation
Aiming Aiming 11/01/2012 1 month $139.13 $149.09 +7.16% 7 Ended
Comments: strong product

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.